100047-42-5

Basic information

• Product Name: 6-(Methylthio)-1H-pyrazolo[3,4-d]pyriMidin-3(2H)-one
• Synonyms: 6-(Methylthio)-1H-pyrazolo[3,4-d]pyriMidin-3(2H)-one;1,2-Dihydro-6-(methylthio)-3H-pyrazolo[3,4-d]pyrimidin-3-one;6-Methylsulfanyl-1,2-dihydro-pyrazolo[3,4-d]pyrimidin-3-one
• CAS NO: 100047-42-5
• Molecular Formula: C₆H₆N₄OS
• Molecular Weight: 182.20304
• Mol File: 100047-42-5.mol

Chemical Properties

• Appearance: /
• Density: 1.78
• CAS DataBase Reference: 6-(Methylthio)-1H-pyrazolo[3,4-d]pyriMidin-3(2H)-one(CAS DataBase Reference)
• NIST Chemistry Reference: 6-(Methylthio)-1H-pyrazolo[3,4-d]pyriMidin-3(2H)-one(100047-42-5)
• EPA Substance Registry System: 6-(Methylthio)-1H-pyrazolo[3,4-d]pyriMidin-3(2H)-one(100047-42-5)

Safety Data

• Hazardous Substances Data: 100047-42-5(Hazardous Substances Data)

Usage

Uses

Used in Pharmaceutical Industry:
6-(Methylthio)-1H-pyrazolo[3,4-d]pyriMidin-3(2H)-one is used as a pharmaceutical intermediate for the development of new drugs. Its unique structure and properties may contribute to the discovery of novel therapeutic agents with specific biological activities.
Used in Organic Synthesis:
6-(Methylthio)-1H-pyrazolo[3,4-d]pyriMidin-3(2H)-one is used as a building block in organic synthesis for the creation of various organic compounds. Its pyrazolopyrimidine structure and methylthio group can be utilized to synthesize a range of molecules with potential applications in different fields.
Used in Research and Development:
6-(Methylthio)-1H-pyrazolo[3,4-d]pyriMidin-3(2H)-one is used as a research compound to explore its potential uses and limitations in various applications. Further studies may be necessary to fully understand its properties and to identify new areas where it can be applied effectively.

Upstream product

• 117147-06-5 ethyl 4-hydrazinyl-2-(methylsulfanyl)pyrimidine-5-carboxylate 
• 5909-24-0 4-chloro-2-methanesulfanylpyrimidine-5-carboxylic acid ethyl ester 

Downstream Products

• 1306830-00-1 1-cyclohexyl-3-phenyl-N-propyl-1H-pyrazolo[3,4-d]pyrimidin-6-amine 
• 1306830-01-2 C₂₁H₂₅N₅O₂ 
• 1306830-02-3 C₂₂H₂₇N₅O₂ 
• 1306830-03-4 C₁₈H₂₃N₅O 
• 1306830-05-6 tert-butyl 4-((3-(2-methoxyphenyl)-6-(propylamino)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)methyl)piperidine-1-carboxylate 
• 1306830-06-7 C₂₁H₂₈N₆O 
• 1306829-95-7 3-bromo-6-(methylsulfanyl)-1H-pyrazolo[3,4-d]pyrimidine 
• 1306830-08-9 C₂₂H₂₀N₆ 
• 1306830-10-3 1-isopropyl-3-phenyl-N-propyl-1H-pyrazolo[3,4-d]pyrimidin-6-amine 
• 1306830-11-4 C₁₈H₂₁N₅ 
• 1306830-12-5 C₁₆H₁₉N₅ 
• 1306830-13-6 C₁₉H₁₉N₅O 
• 1306830-14-7 1-isopropyl-N,3-diphenyl-1H-pyrazolo[3,4-d]pyrimidin-6-amine 
• 1306830-15-8 C₂₁H₂₁N₅O 

Relevant articles and documents

A new method for the chemical synthesis of the Wee1 protein kinase inhibitor adavosertib

The present invention relates to a New Method for the Chemical Synthesis of a Weather1 protein kinase inhibitor adavosertib. The method of the present invention, using an intermediate compound that is commercially readily available, which undergoes a micr

MERTK DEGRADERS AND USES THEREOF

The present invention provides compounds, compositions thereof, and methods of using the same.

PHENOXYMETHYL DERIVATIVES

The invention provides novel compounds having the general formula (I), wherein RA, RB, RC, RC1 and W are as defined herein, compositions including the compounds and methods of using the compounds.

ALKYNYL ALCOHOLS AND METHODS OF USE

The invention relates to compounds of Formula (0): wherein Q, A1-A8, R4 and R5 and each has the meaning as described herein. Compounds of Formula (0) and pharmaceutical compositions thereof are useful in the treatment of diseases and disorders in which undesired or over- activation of NF-kB signaling is observed.

Microwave-assisted, divergent solution-phase synthesis of 1,3,6-trisubstituted pyrazolo[3,4- d ]pyrimidines

A concise and highly divergent synthetic route has been developed to rapidly access 1,3,6-trisubstituted pyrazolopyrimidines. The synthesis features a microwave assisted one-pot N1-alkylation/Suzuki-Miyaura reaction as the key step. The sequence of the synthetic scheme can be varied to selectively modify the N1, C3, or C6 position at a late synthetic stage, thereby providing a highly efficient approach to explore the structure-activity relationships of pyrazolopyrimidine derivatives. The scope of these reactions has also been explored.